Lu-177 production begins at Canada’s Bruce NPP

Framatome and SN Nuclearelectrica, a partially state-owned Romanian nuclear energy company, have entered into a long-term cooperation agreement to produce the medical isotope lutetium-177 at...

Framatome’s enhanced accident tolerant fuel assemblies recently completed a third 18-month fuel cycle at Southern Nuclear’s Vogtle-2 plant—the first of this type of fuel to reach this...

The Department of Energy announced contracts yesterday for six companies to perform high-assay low-enriched uranium (HALEU) deconversion and to transform enriched uranium hexafluoride (UF6) to...

TerraPower Isotopes, a subsidiary of Bellevue, Wash.–based TerraPower, announced it is now producing actinium-225 at commercial scale, making the medical isotope available to the...

As Bruce Power continues predevelopment work, public input is being sought on the potential Bruce C nuclear power expansion project in Ontario.Bruce Power recently submitted its initial...

Bruce Power has announced the completion of its Unit 3 reactor removal—a milestone on its Major Component Replacement (MCR) project aimed at extending the Bruce plant’s operational life...